Full text is available at the source.
Nephrology: What You May Have Missed in 2024
Important Kidney Research Updates You Might Have Missed in 2024
AI simplified
Abstract
Four studies in 2024 examined chronic kidney disease progression and cardiovascular events related to semaglutide or sodium-glucose cotransporter-2 inhibitors.
- Studies assessed the relationship between chronic kidney disease and cardiovascular issues concerning specific medications.
- Mineralocorticoid receptor agonists may help manage heart failure in patients with chronic kidney disease.
- Avenciguat could improve albuminuria levels in chronic kidney disease patients.
- Oral phosphate binders are associated with addressing the risk of fractures in chronic kidney disease.
- Inorganic nitrate was shown to reduce the risk of contrast-induced nephropathy.
- A trial indicated that cefepime-taniborbactam may be beneficial for complicated urinary tract infections.
AI simplified